Akdemir O.2024-06-122024-06-1220031302-8723https://hdl.handle.net/20.500.14551/17503[No abstract available]eninfo:eu-repo/semantics/closedAccessAntihypertensive Agent; Dipeptidyl Carboxypeptidase Inhibitor; Glyceryl Trinitrate; Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor; Lisinopril; Simvastatin; Antilipemic Agent; Dipeptidyl Carboxypeptidase Inhibitor; Lisinopril; Simvastatin; Blood Flowmetry; Blood Pressure Monitoring; Blood Pressure Regulation; Brachial Artery; Clinical Trial; Diastolic Blood Pressure; Editorial; Endothelium Cell; Endothelium Lesion; Essential Hypertension; Human; Hyperlipidemia; Monotherapy; Nonparametric Test; Pulse Pressure; Statistical Analysis; Systolic Blood Pressure; Vasodilatation; Blood Pressure; Comparative Study; Controlled Clinical Trial; Drug Combination; Drug Effect; Echography; Hypertension; Note; Pathophysiology; Patient Selection; Physiology; Prospective Study; Pulsatile Flow; Randomized Controlled Trial; Angiotensin-Converting Enzyme Inhibitors; Antilipemic Agents; Blood Pressure; Brachial Artery; Drug Therapy, Combination; Humans; Hypertension; Lisinopril; Patient Selection; Prospective Studies; Pulsatile Flow; Randomized Controlled Trials; SimvastatinEditorial343383392-s2.0-154254276414675885N/A